Kennedy cancels vaccine financing – KFF Health News

Host

The announcement of the Minister of Health and Humanitarian Services, Robert F. Kennedy Junior said that the federal government will cancel nearly $ 500 million in financing flexible research, not only for attention for those who develop vaccines, but also for public health experts who see technology behind the first Covid-19 shots as the best hope in the nation in the future.

President Donald Trump is asking that major pharmaceutical companies offer many American patients the same prices available to patients abroad. This is not the first time that such threats are made, and it is unlikely to volunteer drug makers – who have recorded a few wins against medical care negotiations in the Presidential Tax and spending law – their prices.

The members of this week’s team are Emmarie Huetteman from KFF Health News, Sarah Karlin-Smth from The Pink Sheet, Sandhya Raman of CQ Roll Call and Lauren Weber from The Washington Post.

Among the fast food from this week’s episode:

• Explain the decision to cancel some of the flexible vaccine financing, a priority for vaccine critics, Kennedy has falsely claimed that technology is ineffective against respiratory diseases. The researchers were advancing in the RNA vaccines for diseases such as bird flu and to cancer, and the Trump administration opposition to support the vaccine development weakens the possibilities of future breakthroughs.
• Trump’s insistence that adult drug makers who voluntarily reduce their prices on a few tools that the presidency must provide results on this important pocket issue for many Americans. Medicare’s ability to negotiate the prices of medicines has achieved great success under the Trump tax law and the large spending, which included two rulings defended by the pharmaceutical industry that would delay or exclude some expensive medicines from the process of making deals.
• A year after Trump promised the campaign to secure fertilization coverage in the laboratory, it is said that the White House is not planned to compel insurance companies to pay the price of these price reproductive services – a change that requires a work of Congress and can raise costs in general.
• As Congress returns home to the August holiday and the deadline in late September, the annual government financing process is under progress – but it is unlikely to be resolved quickly or clean. Senators are turning more in their work than usual, but the House of Representatives has not yet issued its copy, which is expected to reduce social issues deeper and hit them, such as more difficult abortion.

In addition, for “additional credit”, the committee members suggest the health policy stories they read (or write) this week and which they believe should also be read:

Emmarie Huetteman: KFF Health NewsNew Federal Medical Work requirements mean less periods for the states“Posted by Catherine Hutton and Bram Silm Smith.

Sarah Carlin Smith: Slit “Confessions of the Queen of Social Welfare“Written by Maria Kivlas.

Sandia Raman: CQ Roll Call “Pushing Sweden products to products that do not smoke to question the risks“Posted by Sandia Raman.

Lauren Weber: The New York Times“Hot Wasps” is located in the nuclear facility in South Carolina“By Emily Antis.

Also mentioned in the podcast this week:

To hear all our podcasts, Click here.

And subscribe to Kff Health News. “What is health? ” on Spotifyand Apple podcastand Pocket castsOr wherever you listen to the podcast.